Results 281 to 290 of about 933,480 (358)
All-comEr Registry of OCT (AERO) to Investigate the MLD-MAX Algorithm for OCT-guided-precision-PCI in Daily Routine: Rationale and Study Design of ILUMIEN-V-AERO. [PDF]
Mohan NC +9 more
europepmc +1 more source
C-Ply (Trademark) NCF Carbone extra fin : Etude du procédé de fabrication et optimisation du renfort
Vicky Singery
openalex +1 more source
Optimisation de la génération symbolique du code et estimation des paramètres dynamiques de structures mécaniques dans SYMOFROS [PDF]
Brian C. J. Moore
openalex
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Implementation of an ERAS<sup>®</sup> Programme for Total Hip and Knee Arthroplasty in a High-Volume University Hospital. [PDF]
Albrecht E +3 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
IonBench: A benchmark of optimisation strategies for mathematical models of ion channel currents. [PDF]
Owen MJ, Mirams GR.
europepmc +1 more source
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah +7 more
wiley +1 more source

